| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 5 |
| 1 | IPILIMUMAB | 4 |
| 2 | AXITINIB | 2 |
| 3 | CRIZOTINIB | 2 |
| 4 | DABRAFENIB | 2 |
| 5 | ERLOTINIB | 2 |
| 6 | ERLOTINIB HYDROCHLORIDE | 2 |
| 7 | FLUOROURACIL | 2 |
| 8 | FLUOROURACIL CREAM, 0.5% | 2 |
| 9 | IMATINIB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELINOSTAT | 1 | 0.0028 |
| 1 | PLATINUM | 1 | 0.0019 |
| 2 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| 3 | TAZEMETOSTAT | 1 | 0.0006 |
| 4 | LEVOLEUCOVORIN INJECTION | 1 | 0.0003 |
| 5 | CLINDAMYCIN PHOSPHATE TOPICAL | 1 | 0.0003 |
| 6 | LEVOLEUCOVORIN | 1 | 0.0003 |
| 7 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 8 | REGORAFENIB | 2 | 0.0002 |
| 9 | VEMURAFENIB | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5 | 0.0001 |
| 3 | Leukocyte Growth Factor [EPC] | 2 | 0.0000 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Fluoroquinolone Antibacterial [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 3 | 0.0000 |